News

The director of the Joseph Epstein Center for Emergency Medicine Research provided context on the types of research needed to further evaluate and improve diagnosis and management of headache in emergency departments. [WATCH TIME: 3 minutes]

Favorable outcome, defined as modified Rankin Scores of 0-2, was achieved in patients presenting with ASPECTS of 2-5 regardless of treatment with mechanical thrombectomy in the early or extended windows.

The research assistant professor at the Buffalo Neuroimaging Analysis Center provided context on how different forms of multiple sclerosis impact cognitive decline in patients. [WATCH TIME: 3 minutes]

The study authors concluded that while there are differences in survival between specific ASMs, lamotrigine and levetiracetam appear to be reasonable first-line treatment options for patients with poststroke epilepsy.

Heidi Schwarz, MD, offers her perspective on the role of advanced practice providers in clinical neurological care and the benefit that they provide to practices.

The latest CME course features a trio of experts that will help advanced practice providers provide optimal patient management and education in DBS treatment.

The founder of MS Bites discussed the role dietitians can play in care of patients with MS, noting that they have not historically been included in the comprehensive care team, and differentiating their approaches to care. [WATCH TIME: 2 minutes]

Anita Shelgikar, MD, MHPE, discussed a recent study from which data suggested a statistically significant improvement in sleep medicine knowledge following a 2-day introductory course.

The safety profile in the low-dose cohort (6 x 1012 vg) is supportive of continued enrollment for a higher-dose cohort of 6 x 1013 vg. Additional data are anticipated to be announced in the second quarter of 2022.

The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the thought behind STOPS2, a trial aimed at preventing or delaying seizure onset in tuberous sclerosis complex. [WATCH TIME: 3 minutes]

Here's what is coming soon to NeurologyLive®.

Amid a changing and evolving landscape for adult migraine care, Christina Szperka, MD, MSCE, director of the CHOP Pediatric Headache Program, offered insight into the standard experience in pediatric migraine care.

The registered dietitian and founder of MS Bites spoke on changes in symptom care for patients with MS, as well as the sustained benefits of telehealth. [WATCH TIME: 2 minutes]

Christina Szperka, MD, MSCE, director of the CHOP Pediatric Headache Program, shared her perspective on the state of care and awareness for pediatric migraine amid the shifting landscape for adults.

Neurology News Network for the week ending January 1, 2022. [WATCH TIME: 4 minutes]

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 31, 2021.

Check out the top stories from the field of sleep medicine from our coverage in 2021, including new understandings of insomnia and daytime sleepiness.

Take a look back at some of the most-viewed, top video series with key experts in neurology and their in-depth discussions, part of NeurologyLive®'s Year in Review.

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Jennifer Majersik, MD, MS.

What excites you? What awakens your sense of purpose? What gives your life meaning? Bradley McDaniels, PhD, CRC, explores the importance of meaning in one's life.

These news stories in stroke and cerebrovascular disease were top of mind in the conversations in the field and were often included in NeurologyLive®’s coverage.

As part of NeurologyLive®'s Year in Review, take a look at some of the most engaging conversations the team has had with experts in neurology this past year.

The clinical associate professor of neurology at the University of Michigan spoke on the importance of sleep medicine education for trainees, as well as areas that could be improved. [WATCH TIME: 3 minutes]

Patients with and without a history of aura had similar reductions in monthly migraine days and monthly acute migraine-specific medication usage after treatment with erenumab.

The Distinguished Professor of Neuromuscular Disease at University of North Carolina School of Medicine offered his insight into the newly approved Argenx agent, marketed as Vyvgart. [WATCH TIME: 3 minutes]

We’ve compiled the top stories from 2021 across the breadth of the neuromuscular field, from clinical developments to conversations in management and beyond.

As part of NeurologyLive®'s Year in Review, take a look at some of the most listened to and engaging conversations from the Mind Moments™ podcast from this past year.

The director of the Joseph Epstein Center for Emergency Medicine Research provided context on a study that showed wide variation in EDs diagnosis, treatment, and management of headache.